MACROGENICS, INC. Unrealized Gain (Loss) on Investments
MACROGENICS, INC. (MGNX) reported Unrealized Gain (Loss) on Investments of $12.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2026-08-14
- MACROGENICS, INC. unrealized gain (loss) on investments for the quarter ending 2026-06-30 was $12.00K.
- MACROGENICS, INC. unrealized gain (loss) on investments for the quarter ending 2026-03-31 was -$59.00K.
- MACROGENICS, INC. unrealized gain (loss) on investments for the quarter ending 2025-09-30 was $12.00K, a 68.42% decline year-over-year.
- MACROGENICS, INC. unrealized gain (loss) on investments for the quarter ending 2025-06-30 was -$6.00K, a 154.55% decline year-over-year.
- MACROGENICS, INC. unrealized gain (loss) on investments for fiscal 2025 was $28.00K, a 180.00% increase from fiscal 2024.
- MACROGENICS, INC. unrealized gain (loss) on investments for fiscal 2024 was $10.00K.
- MACROGENICS, INC. unrealized gain (loss) on investments for fiscal 2023 was -$1.00K, a 101.79% decline from fiscal 2022.
- MACROGENICS, INC. unrealized gain (loss) on investments for fiscal 2022 was $56.00K.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 6 month | Unrealized Gain (Loss) on Investments 9 month | Unrealized Gain (Loss) on Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $12.00K 10-Q · filed 2026-08-14 | -$47.00K derived: sum of 2 quarters · filed 2026-08-14 | ||
| 2026-03-31 | -$59.00K 10-Q · filed 2026-08-14 | |||
| 2025-12-31 | $28.00K 10-K · filed 2026-03-09 | |||
| 2025-09-30 | $12.00K 10-Q · filed 2025-11-12 | $6.00K derived: sum of 2 quarters · filed 2026-08-14 | $1.00K derived: sum of 3 quarters · filed 2026-08-14 | |
| 2025-06-30 | -$6.00K 10-Q · filed 2026-08-14 | -$11.00K derived: sum of 2 quarters · filed 2026-08-14 | ||
| 2025-03-31 | -$5.00K 10-Q · filed 2026-08-14 | |||
| 2024-12-31 | $10.00K 10-K · filed 2026-03-09 | |||
| 2024-09-30 | $38.00K 10-Q · filed 2025-11-12 | $49.00K derived: sum of 2 quarters · filed 2025-11-12 | $20.00K derived: sum of 3 quarters · filed 2025-11-12 | |
| 2024-06-30 | $11.00K 10-Q · filed 2025-11-12 | -$18.00K derived: sum of 2 quarters · filed 2025-11-12 | ||
| 2024-03-31 | -$29.00K 10-Q · filed 2025-11-12 | |||
| 2023-12-31 | -$1.00K 10-K · filed 2026-03-09 | |||
| 2023-09-30 | $38.00K 10-Q · filed 2024-11-05 | -$42.00K derived: sum of 2 quarters · filed 2024-11-05 | -$29.00K derived: sum of 3 quarters · filed 2024-11-05 | |
| 2023-06-30 | -$80.00K 10-Q · filed 2024-11-05 | -$67.00K derived: sum of 2 quarters · filed 2024-11-05 | ||
| 2023-03-31 | $13.00K 10-Q · filed 2024-11-05 | |||
| 2022-12-31 | $56.00K 10-K · filed 2025-03-20 | |||
| 2022-09-30 | $213.00K 10-Q · filed 2023-11-06 | $170.00K derived: sum of 2 quarters · filed 2023-11-06 | -$52.00K derived: sum of 3 quarters · filed 2023-11-06 | |
| 2022-06-30 | -$43.00K 10-Q · filed 2023-11-06 | -$265.00K derived: sum of 2 quarters · filed 2023-11-06 | ||
| 2022-03-31 | -$222.00K 10-Q · filed 2023-11-06 | |||
| 2021-12-31 | -$54.00K 10-K · filed 2024-03-07 | |||
| 2021-09-30 | -$4.00K 10-Q · filed 2022-11-03 | -$14.00K derived: sum of 2 quarters · filed 2022-11-03 | $4.00K derived: sum of 3 quarters · filed 2022-11-03 | |
| 2021-06-30 | -$10.00K 10-Q · filed 2022-11-03 | $8.00K derived: sum of 2 quarters · filed 2022-11-03 | ||
| 2021-03-31 | $18.00K 10-Q · filed 2022-11-03 | |||
| 2020-12-31 | -$23.00K 10-K · filed 2023-03-15 | |||
| 2020-09-30 | -$15.00K 10-Q · filed 2021-11-02 | -$70.00K derived: sum of 2 quarters · filed 2021-11-02 | -$14.00K derived: sum of 3 quarters · filed 2021-11-02 | |
| 2020-06-30 | -$55.00K 10-Q · filed 2021-11-02 | $1.00K derived: sum of 2 quarters · filed 2021-11-02 | ||
| 2020-03-31 | $56.00K 10-Q · filed 2021-11-02 | |||
| 2019-12-31 | $19.00K 10-K · filed 2022-02-24 | |||
| 2019-09-30 | -$11.00K 10-Q · filed 2020-11-04 | $23.00K derived: sum of 2 quarters · filed 2020-11-04 | $26.00K derived: sum of 3 quarters · filed 2020-11-04 | |
| 2019-06-30 | $34.00K 10-Q · filed 2020-11-04 | $37.00K derived: sum of 2 quarters · filed 2020-11-04 | ||
| 2019-03-31 | $3.00K 10-Q · filed 2020-11-04 | |||
| 2018-12-31 | $58.00K 10-K · filed 2021-02-25 | |||
| 2018-09-30 | -$17.00K 10-Q · filed 2019-11-06 | $23.00K derived: sum of 2 quarters · filed 2019-11-06 | $61.00K derived: sum of 3 quarters · filed 2019-11-06 | |
| 2018-06-30 | $40.00K 10-Q · filed 2019-11-06 | $78.00K derived: sum of 2 quarters · filed 2019-11-06 | ||
| 2018-03-31 | $38.00K 10-Q · filed 2019-11-06 | |||
| 2017-12-31 | $21.00K 10-K · filed 2020-02-25 | |||
| 2016-12-31 | -$77.00K 10-K · filed 2019-02-26 | |||
| 2015-12-31 | -$5.00K 10-K · filed 2018-02-27 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |